Philips EPIQ Diagnostic Ultrasound System
by Philips
· Based in Netherlands →
— Advanced Diagnostic Ultrasound Systems for Confident Clinical Decisions
Contact vendor for pricing
Regulatory Status Disclosed
Overview
The Philips EPIQ Diagnostic Ultrasound System is a premium imaging platform designed to deliver high-resolution diagnostic capabilities across a variety of clinical applications. The system is built for healthcare facilities requiring advanced diagnostic imaging, including hospitals, dedicated imaging centers, and high-volume clinics. It supports multiple medical specialties such as cardiology, radiology, obstetrics and gynecology, pediatrics, and vascular medicine.
To optimize clinical and practice workflows, the EPIQ platform features a standardized user interface and transducer compatibility shared with other Philips systems. This design consistency simplifies staff onboarding and allows clinicians to transition between different machines with minimal training. The system integrates automated tools that reduce manual keystrokes, helping to accelerate exam times and standardize protocols across departments.
Notable capabilities of the EPIQ system include:
- Integrated AI Solutions: Automated features assist with image acquisition, view preselection, and quantitative measurements, which helps reduce user-to-user variability.
- xMATRIX Technology: Supports rapid volume acquisition and multiple imaging modes, including 2D, 3D/4D, and Live xPlane, using a single transducer.
- Advanced Quantification Tools: Features specialized software such as 3D Auto Color Flow Quantification and 3D Auto Tricuspid Valve Quantification to assist in cardiac assessments.
- Collaboration Live: Enables remote system access, real-time clinical consultation, and remote troubleshooting.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-based capabilities for image acquisition and analysis, including AutoStrain and Smart View Select for cardiac assessment, and Auto ElastQ for liver elastography.
- Superior image quality with technologies like nSIGHT Imaging architecture, PureWave transducers, and Precision Beamforming.
- Elastography (Shear Wave and Strain) for quantitative assessment of tissue stiffness.
- Advanced 3D/4D imaging with TrueVue and FlexVue for photorealistic rendering and visualization of anatomical structures.
- Workflow automation tools such as AutoScan, SmartExam, and Auto Doppler optimization to reduce button pushes and enhance efficiency.
- Ergonomic design with articulating monitors (up to 24-inch HD display) and tablet-like touchscreen user interfaces for enhanced scanning comfort.
- Flow Viewer for 3D-like rendering of flow imaging data, providing clarity and boundary definition.
- MicroFlow Imaging (MFI) designed to detect slow and weak blood flow in tissue.
- xMATRIX transducer technology offering all imaging modes in a single transducer for versatile data acquisition.
- Tissue Specific Presets (TSPs) that automatically adjust over 7500 parameters to optimize the transducer for specific exam types.
Use Cases
- Comprehensive cardiovascular assessment, including adult and pediatric echocardiography, stress echo, and advanced cardiac analysis.
- Detailed obstetrics and gynecology imaging, including fetal assessment, women's health, and breast studies.
- General radiology applications such as abdominal, small parts (breast, thyroid, testicle), and musculoskeletal imaging.
- Vascular assessment and diagnosis, including peripheral vessel imaging.
- Point-of-Care diagnostics in emergency departments (ED), intensive care units (ICU), and for bedside checks.
- Liver health assessment through automated liver elastography (Auto ElastQ) and quantitative shear wave measurements.
Details
| Category | Radiology & Imaging AI |
| Pricing |
Contact vendor for pricing
|
| Deployment | On-premise (cart-based system) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
1 AI-estimated Both Philips EPIQ and Affiniti Diagnostic Ultrasound Systems received 510(k) clearance (K212704) from the U.S. FDA on September 24, 2021, for diagnostic ultrasound imaging and fluid flow analysis of the human body across various indications for use, including abdominal, cardiac, fetal/obstetric, gynecological, vascular, and musculoskeletal applications. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Gastroenterology, Radiology |
What the Web Says
The Philips EPIQ Diagnostic Ultrasound System is an advanced imaging device used for various diagnostic ultrasound applications across multiple anatomical regions. It features AI-powered Auto Measure software for semi-automated 2D and Doppler measurements during echocardiography, aiming to enhance efficiency and consistency in assessments. The system is designed for use in clinics, hospitals, and point-of-care settings, and can be integrated with other Philips systems for image guidance during cardiovascular procedures.
Overall: PositiveStrengths
- AI-powered Auto Measure feature for semi-automated measurements in echocardiography, improving efficiency and consistency
- Versatile for diagnostic ultrasound imaging and fluid flow analysis in multiple anatomical regions
- Suitable for use in various clinical environments including hospitals, clinics, and point-of-care
- Can be integrated with Philips EchoNavigator for image guidance during cardiovascular disease treatment
- Offers 2D and/or 3D ultrasound imaging capabilities depending on the system model and configuration
- Designed with robust internal controls, including risk management and software verification and validation
Limitations
- No specific predicate devices were specified in one FDA document
- The system requires appropriately trained healthcare professionals for operation
- Some transducers may have higher frequencies compared to existing compatible transducers, though within FDA limits
- One FDA document mentions a Class 2 Device Recall for the Philips EPIQ Diagnostic Ultrasound System, though details are not provided in the snippet
- Limited information available from independent tech reviewers, Reddit, G2, or Capterra in the search results.
- The VeriSight/VeriSight Pro ICE catheters are for exclusive use with specific Philips EPIQ series ultrasound systems
Based on reviews from: FDA Radiology AI Device - X-ray Interpreter (RadAI Slice), accessdata.fda.gov, iData Research, PMC, ResearchGate
Last updated: 2026-07-19
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Philips EPIQ Diagnostic Ultrasound System
Press & Coverage
FDA
Class 2 Device Recall Philips EPIQ Diagnostic Ultrasound System
Philips Ultrasound, Inc. initiated a Class 2 Device Recall for certain Philips EPIQ Diagnostic Ultrasound System models due to a potential issue where systems operating with software version 10.0 may display a delayed image instead of a real-time image. The company issued an Urgent Medical Device Correction notification to affected users in October 2023.
2023-11
Thermopolis Independent Record Archives
Helmsley Charitable Trust grants $346,794 to Hot Springs Health for Philips Epiq Diagnostic Ultrasound System
The Leona M. and Harry B. Helmsley Charitable Trust awarded Hot Springs Health a grant of $346,794.00 to acquire a Philips Epiq Diagnostic Ultrasound System and eight Philips Lumify Point-of-Care ultrasound units. This is part of a larger statewide initiative in Wyoming to enhance ultrasound imaging capabilities and training.
2024-03
RadAI Slice
EPIQ Series Diagnostic Ultrasound System FDA Approval with AI-powered Auto Measure
The Philips EPIQ and Affiniti Series Diagnostic Ultrasound Systems received FDA approval on September 8, 2021, for their AI-powered Auto Measure feature. This feature semi-automates 2D and Doppler measurements during echocardiography, aiming to improve efficiency and standardization in assessments.
2021-09
accessdata.fda.gov
FDA 510(k) Premarket Notification for EPIQ Series Diagnostic Ultrasound System (K233545)
A 510(k) premarket notification was submitted for the EPIQ Series Diagnostic Ultrasound System, including the X11-4t transducer, which is a 3D transesophageal cardiac transducer. The system is intended for diagnostic ultrasound imaging and fluid flow analysis in various anatomical regions.
2023-11
accessdata.fda.gov
FDA 510(k) Premarket Notification for VeriSight/VeriSight Pro ICE Catheters with Philips EPIQ Diagnostic Ultrasound System (K251103)
Philips Image Guided Therapy Corporation received FDA approval for their VeriSight/VeriSight Pro ICE catheters, which are designed for exclusive use with Philips EPIQ 7C, CVx, and CVxi series ultrasound systems. These catheters provide 2D and/or 3D ultrasound imaging for intracardiac and intra-luminal visualization during cardiac procedures.
2025-05
PMC
Comparison of Different Ultrasound Protocols in Patients with Inflammatory Polyneuropathies with Practical Insights
A study published in June 2025 utilized a Philips EPIQ 7 ultrasound machine with a linear 4u201318 MHz transducer for examining peripheral nerves in patients with inflammatory polyneuropathies. The research aimed to compare different ultrasound protocols for diagnosing these conditions.
2025-06
MDPI
Invasive and Echocardiographic Mean Transvalvular Pressure Gradients of Different Transcatheter Aortic Valve Prostheses
Research published in August 2025 involved the use of a Philips EPIQ diagnostic ultrasound system for postoperative transthoracic echocardiographic evaluation of mean pressure gradients in patients who underwent transcatheter aortic valve replacements. The study aimed to compare invasive and echocardiographic measurements.
2025-08
PMC
Cross-Sectional Area and Echogenicity Reference Values for Sonography of Peripheral Nerves in the Lithuanian Population
A study conducted from April 2022 to October 2023, and published in June 2024, utilized a Philips EPIQ 7 ultrasound machine to establish reference values for cross-sectional area and echogenicity of peripheral nerves in a healthy Lithuanian adult cohort.
2024-06
Videos
Product demos, reviews, and walkthroughs for Philips EPIQ Diagnostic Ultrasound System.
Philips Ultrasound EPIQ CVx 2D Optimisation
Frequently Asked Questions
The Philips EPIQ system integrates AI to automate various tasks, such as image acquisition, measurements, and analysis, aiming to streamline workflows and reduce exam times. Features like AutoStrain and SmartView Select assist in selecting optimal views and performing consistent cardiac measurements, thereby enhancing diagnostic confidence and reducing inter-user variability.
Philips is committed to stringent data protection and privacy, with its AI systems complying with applicable privacy laws and FDA ultrasound guidance documents. The company adheres to principles of human oversight, safety, fairness, transparency, security, and privacy, ensuring that AI augments clinical decisions while safeguarding patient data.
A key limitation is the inherent operator dependency of ultrasound, meaning AI cannot compensate for incomplete or poorly acquired data, and image variability can affect AI algorithm accuracy. Physicians must also be mindful of potential 'automation bias' and remember that AI serves as a decision-support tool, with ultimate diagnostic responsibility remaining with the clinician.
Leading alternatives in the ultrasound AI market include systems from GE Healthcare, such as the Voluson E10 for women's health or the Logiq E10 for general imaging, and Siemens Healthineers' ACUSON series. Other notable competitors offering AI-enabled ultrasound solutions include Samsung Medison and Mindray.
The cost of a new Philips EPIQ Elite system typically ranges from $120,000 to $175,000, depending on the specific configuration, number of transducers, and advanced software options. Refurbished models, such as the EPIQ Elite, can be found for an average of $37,350 to $49,999, with prices varying based on the model and included features.
Compare Philips EPIQ Diagnostic Ultrasound System
Suggest an Edit →
| Last Verified: 2026-04-19 | First Added: 2026-04-19